The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cross-talk between the insulin and angiotensin signaling systems.
Open accessAbstract
Angiotensin II (AII), acting via its G-protein linked receptor, is an important regulator of cardiac, vascular, and renal function. Following injection of AII into rats, we find that there is also a rapid tyrosine phosphorylation of the major insulin receptor substrates 1 and 2 (IRS-1 and IRS-2) in the heart. This phenomenon appears to involve JAK2 tyrosine kinase, which associates with the AT1 receptor and IRS-1/IRS-2 after AII stimulation. AII-induced phosphorylation leads to binding of phosphatidylinositol 3-kinase (PI 3-kinase) to IRS-1 and IRS-2; however, in contrast to other ligands, AII injection results in an acute inhibition of both basal and insulin-stimulated PI 3-kinase activity. The latter occurs without any reduction in insulin receptor or IRS phosphorylation or in the interaction of the p85 and p110 subunits of PI 3-kinase with each other or with IRS-1/IRS-2. These effects of AII are inhibited by AT1 receptor antagonists. Thus, there is direct cross-talk between insulin and AII signaling pathways at the level of both tyrosine phosphorylation and PI 3-kinase activation. These interactions may play an important role in the association of insulin resistance, hypertension, and cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Franke, T. F., Yang, S.-I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., & Tsichlis, P. N. (1995) · Cell · doi:10.1016/0092-8674(95)90534-0 · Cited by 2,006
White, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,723
Self-citationCheatham, B., Vlahos, C. J., Cheatham, L., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902 · Cited by 1,068
Self-citationIdentification of JAK2 as a growth hormone receptor-associated tyrosine kinase
Argetsinger, L. S., Campbell, G. S., Yang, X., Witthuhn, B. A., Silvennoinen, O., Ihle, J. N., & Carter-Su, C. (1993) · Cell · doi:10.1016/0092-8674(93)90415-m · Cited by 974
Role of IRS-2 in insulin and cytokine signalling
Sun, X. J., Wang, L.-M., Zhang, Y., Yenush, L., Myers Jr, M. G., Glasheen, E., Lane, W. S., Pierce, J. H., & White, M. F. (1995) · Nature · doi:10.1038/377173a0 · Cited by 848
Self-citationZavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P. A., Bergonzani, M., Gnudi, L., Passeri, M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201105 · Cited by 771
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
Marrero, M. B., Schieffer, B., Paxton, W. G., Heerdt, L., Berk, B. C., Delafontaine, P., & Bernstein, K. E. (1995) · Nature · doi:10.1038/375247a0 · Cited by 745
PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase
Chung, J., Grammar, T. C., Lemon, K. P., Kazlauskas, A., & Blenis, J. (1994) · Nature · doi:10.1038/370071a0 · Cited by 719
Cloning and Characterization of a G Protein-Activated Human Phosphoinositide-3 Kinase
Stoyanov, B., Volinia, S., Hanck, T., Rubio, I., Loubtchenkov, M., Malek, D., Stoyanova, S., Vanhaesebroeck, B., Dhand, R., Nürnberg, B., et al. (1995) · Science · doi:10.1126/science.7624799 · Cited by 675
Dhand, R., Hiles, I., Panayotou, G., Roche, S., Fry, M. J., Gout, I., Totty, N. F., Truong, O., Vicendo, P., & Yonezawa, K. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06290.x · Cited by 446
Baron, A. D., Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., & Brechtel, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118124 · Cited by 380
Increasing cAMP attenuates activation of mitogen-activated protein kinase.
Sevetson, B. R., Kong, X., & Lawrence, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10305 · Cited by 371
White, M. F., Livingston, J. N., Backer, J. M., Lauris, V., Dull, T. J., Ullrich, A., & Kahn, C. R. (1988) · Cell · doi:10.1016/s0092-8674(88)80008-4 · Cited by 369
Self-citationKeegan, A. D., Nelms, K., White, M., Wang, L.-M., Pierce, J. H., & Paul, W. E. (1994) · Cell · doi:10.1016/0092-8674(94)90356-5 · Cited by 303
Self-citationLinseman, D. A., Benjamin, C. W., & Jones, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12563 · Cited by 289
Shepherd, P. R., Navé, B. T., & Siddle, K. (1995) · Biochemical Journal · doi:10.1042/bj3050025 · Cited by 277
Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling
Yamauchi, K., Milarski, K. L., Saltiel, A. R., & Pessin, J. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.664 · Cited by 263
Folli, F., Saad, M. J., Backer, J. M., & Kahn, C. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41650-x · Cited by 254
Self-citationArgetsinger, L. S., Hsu, G. W., Myers, M. G., Billestrup, N., White, M. F., & Carter-Su, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14685 · Cited by 246
Self-citationMendez, R., Myers, M. G., White, M. F., & Rhoads, R. E. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2857 · Cited by 218
Self-citationHypoglycaemia associated with use of inhibitors of angiotensin converting enzyme
Herings, R. M. C., de Boer, A., Leufkens, H. G. M., Porsius, A., & Stricker, B. H. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91988-0 · Cited by 217
Kelly, K. L., & Ruderman, N. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53622-x · Cited by 216
Insulin action impaired by deficiency of the G-protein subunit Giα2
Moxham, C. M., & Malbon, C. C. (1996) · Nature · doi:10.1038/379840a0 · Cited by 214
Servant, M. J., Giasson, E., & Meloche, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16047 · Cited by 171
Rothenberg, P., & Kahn, C. R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37623-9 · Cited by 156
Self-citationACE Inhibitors — A Cornerstone of the Treatment of Heart Failure
Braunwald, E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250508 · Cited by 155
Yin, T., Keller, S. R., Quelle, F. W., Witthuhn, B. A., Tsang, M. L.-S., Lienhard, G. E., Ihle, J. N., & Yang, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20497 · Cited by 151
Zick, Y., Sagi‐Eisenberg, R., Pines, M., Gierschik, P., & Am, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9294 · Cited by 148
O’Brien, R. M., Houslay, M. D., Milligan, G., & Siddle, K. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81361-3 · Cited by 125
Buchanan, T. A., Thawani, H., Kades, W. W., Modrall, J. G., Weaver, F. A., Laurel, C., Poppiti, R., Xiang, A. H., & Hsueh, W. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116642 · Cited by 114
Leduc, I., & Meloche, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4401 · Cited by 96
Kahn, R. (1995) · Nature · doi:10.1038/373384a0 · Cited by 91
Saad, M. J. A., Velloso, L. A., & Carvalho, C. R. D. O. (1995) · Biochemical Journal · doi:10.1042/bj3100741 · Cited by 78
Self-citationMoan, A., Risanger, T., Eide, I. A., & Kjeldsen, S. E. (1994) · Blood Pressure · doi:10.3109/08037059409102250 · Cited by 73
Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor.
Kai, H., Griendling, K. K., Lassegue, B. P., Ollerenshaw, J. D., Runge, M. S., & Alexander, R. W. (1994) · Hypertension · doi:10.1161/01.hyp.24.4.523 · Cited by 63
Valiquette, M., Parent, S., Loisel, T. P., & Bouvier, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00241.x · Cited by 59
Scott, A. L., Chang, R. S., Lotti, V. J., & Siegl, P. K. S. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11166-x · Cited by 59
Saad, M. J. A., Folli, F. B., & Kahn, C. R. (1995) · Endocrinology · doi:10.1210/en.136.4.1579 · Cited by 50
Self-citationCaro, J. F., Raju, M. S., Caro, M., Lynch, C. J., Poulos, J., Exton, J. H., & Thakkar, J. K. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240540307 · Cited by 25
Effects of Diabetes Mellitus on Hepatocyte Nuclear Factor 1 Decrease Albumin Gene Transcription
Barrera-Hernandez, G., Wanke, I. E., & Wong, N. C. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9969 · Cited by 22
Cited by
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
Creager, M. A., Lüscher, T. F., of, P. W. T. A., Cosentino, F., & Beckman, J. A. (2003) · Circulation · doi:10.1161/01.cir.0000091257.27563.32 · Cited by 1,650
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Diabetes, Hypertension, and Cardiovascular Disease: An Update
Sowers, J. R., Epstein, M., & Frohlich, E. D. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1053 · Cited by 1,332
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Metadata
- Authors
- Velloso, L. A., Folli, F., Sun, X. J., White, M. F., Saad, M. J., & Kahn, C. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-10-29
- Volume
- 93
- Issue
- 22
- Pages
- 12490-12495
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2030338284
- Cited by
- 403
- References
- 42
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.